ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633273 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633273; 2) Community: the network communities that were significantly associated with the response to NSC 633273; 3) Molecule: the relationships between components within communities and NSC 633273; 4) MDR: the compounds that were significantly associated with the NSC 633273.

NSC Compound Enrichment Correlation
NSC 335663 ACETYLROLANDROLIDE 0.0414190425892865 0.35323398
NSC 340847 4-Selenazolecarboxamide, 2-.beta.-D-ribofuranosyl- 0.0414190425892865 0.46419223
NSC 372944 Null 0.0414190425892865 0.48335908
NSC 46401 .alpha.-Sarcin 0.0414190425892865 -0.15225477
NSC 58906 9H-Purine, 6-[(o-chlorobenzyl)thio]-9-(2-chloroethyl)- (8CI) 0.0414190425892865 0.29985191
NSC 600758 Null 0.0414190425892865 0.2116981
NSC 606498 Camptothecin Derivative 0.0414190425892865 0.17844411
NSC 609699 Topotecan hydrochloride 0.0414190425892865 0.11113964
NSC 612789 Acrovestone 0.0414190425892865 0.15056476
NSC 620277 4-N,N-bis-2'-cyanoethylaminobenzylidene-4-fluoro aniline 0.0414190425892865 0.2868292
Total:114  Current:88    [First] [Prev] [Next] [Last]